跳至主要内容
临床试验/IRCT201511295225N6
IRCT201511295225N6已完成未知

The effect of labetolol on reducing bleeding during and after functional endoscopic sinus surgery(FESS) in patients scheduled for surgery

Vice chancellor for research, Tehran University of Medical Science0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • informed consent of patients,age between 20 and 60 years old,ASA class I & II, no contraindication for using study drugs,scheduled for functional endoscopic sinus surgery (FESS) Exclusion criteria: need for a different anesthetic regimen, any positive history for coagulation disorders, cerebral/cardiac ischemia, liver,kidney,lung,heart disease or endocrinopathies

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Science

相似试验